Table 2 Treatment strategies and outcomes in patients with corneal suture-related endophthalmitis
From: Delayed-onset endophthalmitis associated with corneal suture infections
Case number | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
Presenting visual acuity | LP | 20/200 | LP | LP | 20/400 | NLP |
Management - topical antibiotics | None | Ceftazidime, vancomycin | Gentamicin, vancomycin | Cefazolin, moxifloxacin, vancomycin | Ceftazidime, moxifloxacin, vancomycin | Ceftazidime, vancomycin |
Management - intravitreal antibiotics | None | Vancomycin | Vancomycin | Vancomycin | Ceftazidime, vancomycin | Ceftazidime, vancomycin |
Management - intravitreal steroids | No | Yes | No | No | Yes | Yes |
Management - penetrating keratoplasty | No | No | Yes | Yes | Yes | No |
Management - vitrectomy | No | Yes | No | No | Yes | No |
Visual acuity at last follow-up visit | NLP/enucleated | LP | LP | 20/200 | 20/150 | NLP/enucleated |